Reaxys® Announces Finalists of the 2013 Reaxys PhD Prize

NEUCHÂTEL, Switzerland, June 6, 2013 /PRNewswire/ --

The Reaxys PhD Prize awards original and innovative research in organic, organometallic and inorganic chemistry

Reaxys today announced the 45 finalists for the 2013 Reaxys PhD Prize. This highly prestigious international prize is open to all students studying for (or having completed in the last 12 months) a PhD in chemistry. The prize recognizes research and publication excellence in chemistry. Entries were reviewed by a board of leading international chemists and judged for originality, innovation, importance to the field, applicability, rigor of approach and publication quality.

The 45 selected finalists are:

Sergey Adonin, Nikolaev Institute of Inorganic Chemistry; Christopher M. Bates, University of Texas; Parijat Borah, Nanyang Technological University; Andrew Cairns, University of Oxford; Christopher Caputo, University of Toronto; Pradip Chakraborty, University of Geneva; Hiroaki Chiba, Kyoto University; Daniel Cohen, Northwestern University; Laurent Debien, Ecole Polytechnique, Paris; Martin Donakowski, Northwestern University; Fabian Ehret, University of Stuttgart; Albert Fahrenbach, Northwestern University; Daishi Fujita, University of Tokyo; Ke Gao, Nanyang Technological; University; Max Hansmann, University of Heidelberg; Chuan He, Wuhan University; Johannes Heppekausen, TU Dortmund; Kenji Hirai, Kyoto University; Yohei Ishida, Tokyo Metropolitan University; Andreas Kaiser, University of Stuttgart; Tzu-Pin Lin, Texas A&M University; Wei Lv, Tianjin University; Emma McInturff, University of Texas; Bill Morandi, ETH Zürich; Shunsuke Oishi, Nagoya University; Sebastian Pike, University of Oxford; Xin Qian, Ecole Polytechnique, Paris; Daniel Robbins, University of Illinois; Dragos Rosca, University of East Anglia; Ramya Sambasivan, Rice University; Santanu Sarkar, University of California, Riverside; Sebastian Schmidt, Karlsruhe Institute of Technology; Mette Schmøkel, Aarhus University; Mika Shiramizu, University of California, Berkeley; Katsuhiko Takeuchi, University of Tsukuba; Gaël Ung, University of California, San Diego; Kevin Williamson, University of Wisconsin-Madison; Gene Wong, University of Wisconsin-Madison; Yuzhou Wu, University of Ulm; Xu Xue, University of South Florida; Xiaoyu Yang, Shanghai Institute of Organic Chemistry; Da-Gang Yu, Peking University; Rong Zeng, Zhejiang University; Gen Zhang, Lanzhou University; Shaoguang Zhang, Peking University.

"Now in its fourth year the Reaxys PhD Prize is truly a premier international prize. We received over 580 submissions this year spread across the chemistry disciplines, from over 60 countries," said Dr. David Evans, Scientific Affairs Director at Reed Elsevier Properties SA. "These 45 finalists join a growing list of some of the rising stars in the chemistry world. Each year we invite the finalists to join the Reaxys Prize Club; promoting networking and collaboration. The club currently includes 135 similar minded individuals, including nearly 20 Assistant Professors, for this year's finalists this is an amazing opportunity to connect with some close peers.

All finalists are invited to attend and present their work at the Reaxys PhD Prize Symposium and Poster Session which will be held at the inaugural Reaxys Inspiring Chemistry Conference, Grindelwald, Switzerland, September 22 - 24, 2013. A travel bursary will be provided to support attendance and registration fees for the conference.

The three winners of the 2013 Reaxys PhD Prize will be selected by the Reaxys PhD prize committee:

Professor A. G. M. Barrett, Imperial College London
Professor Dr M. Jansen, Max Planck Institute, Stuttgart
Professor E. Nakamura, University of Tokyo
Professor G. Parkin, Columbia University, New York
Professor B. M. Trost, Stanford University
Professor H. N. C. Wong, Chinese University of Hong Kong

Winners will be announced mid-June and will each receive $2000 and will be invited to present their research at the 2013 Reaxys PhD Prize Symposium in Grindelwald.

About Reaxys®

Reaxys® is a workflow solution for research chemists. Offering a wealth of experimentally validated information, Reaxys® combines reaction and substance data in organic, organometallic, inorganic and physical chemistry with synthesis planning. Researchers can get the information they need in a single overview, from source publications carefully selected for their importance and relevance to research chemists. Elsevier continues to engage with the chemistry community to ensure that Reaxys® continues to reflect how chemists think and work. For more information please visit http://www.elsevier.com/reaxys

Reaxys® and the Reaxys® trademark are owned and protected by Reed Elsevier Properties SA and used under license.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact
Liz Griffioen
Elsevier
+31-20-485-2247
[email protected]

SOURCE Elsevier and Reaxys